HemaSphere (Jun 2022)

P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION

  • T. Abuasab,
  • E. Jabbour,
  • N. Short,
  • M. Konopleva,
  • K. S. Chien,
  • S. Fareed Mohamed,
  • N. Daver,
  • R. Kanagal-shamanna,
  • G. Garcia-Manero,
  • G. Montalban-Bravo

DOI
https://doi.org/10.1097/01.hs9.0000845900.13105.2e
Journal volume & issue
Vol. 6
pp. 649 – 650

Abstract

Read online

No abstracts available.